Search Results

There are 17288 results for: content related to: Network analysis of drug prescriptions

  1. Evaluation of a program of integrated care to reduce recurrent osteoporotic fractures

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 3, March 2013, Pages: 263–270, Lisa Goltz, Gabriel Degenhardt, Ulf Maywald, Wilhelm Kirch and Christoph Schindler

    Version of Record online : 7 JAN 2013, DOI: 10.1002/pds.3399

  2. Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 7, July 2015, Pages: 771–778, Cristina Bosetti, Matteo Franchi, Federica Nicotra, Rosario Asciutto, Luca Merlino, Carlo La Vecchia and Giovanni Corrao

    Version of Record online : 27 MAY 2015, DOI: 10.1002/pds.3801

  3. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 6, June 2013, Pages: 623–631, Adriana M. Hung, Christianne L. Roumie, Robert A. Greevy, Xulei Liu, Carlos G. Grijalva, Harvey J. Murff and Marie R. Griffin

    Version of Record online : 17 APR 2013, DOI: 10.1002/pds.3432

  4. Additional risk minimisation measures in the EU– are they eligible for assessment?

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1046–1053, Inge M. Zomerdijk, Gianluca Trifirò, Fakhredin A. Sayed-Tabatabaei, Miriam C. J. M. Sturkenboom and Sabine M. J. M. Straus

    Version of Record online : 15 AUG 2013, DOI: 10.1002/pds.3494

  5. Variable selection on large case-crossover data: application to a registry-based study of prescription drugs and road traffic crashes

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 2, February 2014, Pages: 140–151, Marta Avalos, Ludivine Orriols, Hélène Pouyes, Yves Grandvalet, Frantz Thiessard, Emmanuel Lagarde and on behalf of the CESIR research group

    Version of Record online : 18 OCT 2013, DOI: 10.1002/pds.3539

  6. Disease risk score as a confounder summary method: systematic review and recommendations

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 2, February 2013, Pages: 122–129, Mina Tadrous, Joshua J. Gagne, Til Stürmer and Suzanne M. Cadarette

    Version of Record online : 21 NOV 2012, DOI: 10.1002/pds.3377

  7. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  8. Terminal illness and the increased mortality risk of conventional antipsychotics in observational studies: a systematic review

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 2, February 2016, Pages: 113–122, Hendrika J. Luijendijk, Niels C. de Bruin, Tessa A. Hulshof and Xander Koolman

    Version of Record online : 25 NOV 2015, DOI: 10.1002/pds.3912

  9. Impact of antibiotic exposure on the risk of colorectal cancer

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 5, May 2015, Pages: 534–542, Ben Boursi, Kevin Haynes, Ronac Mamtani and Yu-Xiao Yang

    Version of Record online : 23 MAR 2015, DOI: 10.1002/pds.3765

  10. Factors influencing the prescription of drugs of different price levels

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 3, March 2013, Pages: 286–293, Birgitta Semark, Sven Engström, Lars Brudin, Sven Tågerud, Kerstin Fredlund, Lars Borgquist and Göran Petersson

    Version of Record online : 24 JAN 2013, DOI: 10.1002/pds.3402

  11. The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 691–699, B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, AB Almarsdottir, M Andersen, K Andersson Sundell, U Bergman, A Helin-Salmivaara, M Hoffmann, H Kieler, JE Martikainen, M Mortensen, M Petzold, H Wallach-Kildemoes, C Wallin and HT Sørensen

    Version of Record online : 23 MAY 2013, DOI: 10.1002/pds.3457

  12. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1155–1172, Charles E. Leonard, Cristin P. Freeman, Craig W. Newcomb, Peter P. Reese, Maximilian Herlim, Warren B. Bilker, Sean Hennessy and Brian L. Strom

    Version of Record online : 9 AUG 2012, DOI: 10.1002/pds.3329

  13. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 8, August 2015, Pages: 865–874, Bernd Kowall, Andreas Stang, Wolfgang Rathmann and Karel Kostev

    Version of Record online : 1 JUL 2015, DOI: 10.1002/pds.3823

  14. A new “Comparative Effectiveness” assessment strategy using the THIN database: comparison of the cardiac complications of pioglitazone and rosiglitazone

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 1, January 2013, Pages: 86–97, Richard Tannen, Dawei Xie, Xingmei Wang, Menggang Yu and Mark G. Weiner

    Version of Record online : 15 OCT 2012, DOI: 10.1002/pds.3360

  15. A cohort study of therapeutic prescriptions after the end of phytotherapy drug reimbursement by French Social Security

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 7, July 2013, Pages: 760–768, Lionel Riou França, Chrystelle Vidal, Nadia Bourechak, Philippe Le Jeunne, Geoffroy Sainte-Claire Deville and Jacques Massol

    Version of Record online : 4 DEC 2012, DOI: 10.1002/pds.3382

  16. Fall risk increasing drugs and injuries of the frail elderly — evidence from administrative data

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 12, December 2012, Pages: 1321–1327, Thomas K. Bauer, Katharina Lindenbaum, Magdalena A. Stroka, Susanne Engel, Roland Linder and Frank Verheyen

    Version of Record online : 25 OCT 2012, DOI: 10.1002/pds.3357

  17. The impact of diabetes mellitus and its control on the development of tuberculosis: a nationwide longitudinal study in Taiwan

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 9, September 2013, Pages: 995–1003, Ming-Chia Lee, Chih-Hsin Lee, Chin-Chung Shu, Wei-Bang Pong, Chou-Chin Lan, Jann-Yuan Wang, Li-Na Lee and Kun-Mao Chao

    Version of Record online : 30 JUL 2013, DOI: 10.1002/pds.3491

  18. Statins in the prevention of dementia and Alzheimer's disease: A meta-analysis of observational studies and an assessment of confounding

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 4, April 2013, Pages: 345–358, William B. Wong, Vincent W. Lin, Denise Boudreau and Emily Beth Devine

    Version of Record online : 6 DEC 2012, DOI: 10.1002/pds.3381

  19. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 11, November 2012, Pages: 1139–1154, Ana Miguel, Luís Filipe Azevedo, Manuela Araújo and Altamiro Costa Pereira

    Version of Record online : 4 JUL 2012, DOI: 10.1002/pds.3309

  20. Design of a score to identify hospitalized patients at risk of drug-related problems

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 9, September 2014, Pages: 923–932, Olatz Urbina, Olivia Ferrández, Santiago Grau, Sonia Luque, Sergi Mojal, Monica Marin-Casino, Javier Mateu-de-Antonio, Alexia Carmona, David Conde-Estévez, Merce Espona, Elena González, Marta Riu and Esther Salas

    Version of Record online : 10 MAY 2014, DOI: 10.1002/pds.3634